Showing: 1-20 of 2

Melanoma

Melanoma drug holding up well after further testing

Merck’s late-stage melanoma drug, lambrolizumab, continues to show great promise in shrinking the deadly tumors, particularly when taken at the highest dosage offered in trials, according to a study published Thursday in the New England Journal of Medicine.

July 11, 2013 9:03 pmLoading…

St. Gregory Middle School in sun-safety campaign

Skin-cancer study

October 07, 2012 12:05 pmLoading…

Follow the Arizona Daily Star

Featured businesses

View more...
View more...

Event Calendar

Today's events | Add an event

Most viewed: